can coin crypto- Top snippets

European Central Bank President Lagarde: The European Central Bank will pay attention to the impact of the exchange rate on the economy. European Central Bank President Lagarde: The European Central Bank will pay attention to the impact of the exchange rate on the economy.The forecast of the European Central Bank assumes that the exchange rate of the euro against the US dollar will be 1.08 in 2024 and 1.06 in 2025, 2026 and 2027.Trump rang the opening bell of the NYSE and Donald Trump rang the opening bell of the new york Stock Exchange on Thursday, which is a moment worth celebrating for the president-elect. He was named "Person of the Year" by Time magazine. The newspaper awarded this title to the incoming president, because he made a surprising political comeback in the November election and won re-election, and the Republican Party won control of the House and Senate.

Wang Jing, National Endowment Insurance: Opening the market for individual pensions nationwide will usher in a period of historic policy opportunities, and the five departments jointly issued the Notice on the Full Implementation of the Individual Pension System. Wang Jing, head of the market channel department of the national pension insurance, said that after the individual pension is pushed nationwide, it is expected that the market will usher in a historic period of policy opportunities. All kinds of financial institutions will build differentiated and diversified product systems around people's diversified life-cycle pension financial needs, and provide comprehensive services with characteristics and quality, especially for flexible employees and new employment forms, which will further stimulate the whole society's active awareness of pension, accumulate pension financial funds and effectively promote the development of the real economy. (Securities Society)Zhongyin Fashion: Zhongyin Group, the controlling shareholder, intends to transfer some shares of the company by agreement. Zhongyin Fashion announced that Zhongyin Group, the controlling shareholder of the company, intends to transfer 12,024,000 shares of the company's unrestricted shares to Wenwen Fund and Jinhe Investment by agreement transfer. The transferred shares each account for 5.01% of the company's total share capital, accounting for 5.07% of the company's total share capital after excluding the number of shares in the repurchase account. After this equity change, Zhongyin Group holds 94.284 million shares of the company, accounting for 39.29% of the company's total share capital, accounting for 39.79% of the company's total share capital after excluding the number of shares repurchased by the special account; Wenwen Fund and Jinhe Investment each hold 12.024 million shares of the company, each accounting for 5.01% of the company's total share capital, accounting for 5.07% of the company's total share capital after excluding the number of shares repurchased from the special account.Institution: The European Central Bank may further cut interest rates by 100 basis points in 2025. Des Lawrence, an analyst at State Street Global Investment Management, said that after the European Central Bank cut interest rates by 25 basis points, it may cut interest rates by another 100 basis points in 2025. The senior investment strategist said in a report that the European Central Bank can and should cut interest rates further in the coming quarters. Lawrence said that the recent PMI data shows that the economic slowdown is expanding beyond the troubled manufacturing industry, and the service industry is also under pressure.

The weighted share price index of Taiwan Stock Exchange rose 1.2% to 23,170.25 points.European Central Bank President Lagarde: The economy will strengthen over time.Baiyang Pharmaceutical Group signed an agreement with Peking University Hospital. On December 12, Baiyang Pharmaceutical Group signed a cooperation agreement with Peking University No.1 Hospital, and obtained the exclusive right to patent, clinical development and registration, production and marketing of "targeted integrin small molecule inhibitor" in Peking University Hospital.